<DOC>
	<DOCNO>NCT00145210</DOCNO>
	<brief_summary>The purpose study evaluate effect nebivolol blood pressure heart rate African American patient hypertension .</brief_summary>
	<brief_title>Safety Efficacy Nebivolol Treatment Hypertension African Americans</brief_title>
	<detailed_description>Despite establish benefit beta-blockers , use limited side effect profile perception reduce efficacy certain population African Americans ( Amudha , 2003 ) . This double-blind , randomize , placebo active-controlled , multi-center , parallel group , force titration study . Patients stratified across treatment arm age , gender , diabetes status ( history diabetes mellitus vs history diabetes mellitus ) . The study consist 3 period : screen run-in , double-blind , randomize , force titration double-blind , washout period ( patient complete double-blind , force titration period participate long-term follow-up study ) . After 14-28 day , single-blind , placebo control , run-in period , include washout ( applicable ) , eligible patient randomize one 3 treatment regimen approximately 12 week . This study test safety efficacy Nebivolol treatment African American patient hypertension .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>African Americans stage 12 hypertension Recent myocardial infarction stroke Contraindications betablocker therapy stop prior antihypertensive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Nebivolol</keyword>
</DOC>